Corresponding Author: Audina M. Berrocal, MD, Bascom Palmer Eye Institute, 900 NW 17th St, 2nd Floor, Miami, FL 33136 (aberrocal@med.miami.edu).
Published Online: July 21, 2022. doi:10.1001/jamaophthalmol.2022.1653
Conflict of Interest Disclosures: Dr Berrocal has financial interests in Aerie Pharmaceuticals, ProQR Therapeutics, Oculus Surgical, Alcon, Allergan, Bayer, Dutch Ophthalmic Research Center, Phoenix Clinical, Vizunex Medical Systems, Zeiss, and Novartis. No other disclosures were reported.
Funding/Support: This work was supported by National Institutes of Health Center Core grant P30EY014801, Research to Prevent Blindness unrestricted grant GR004596, and US Department of Defense grant W81XWH-13-1-0048.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank the patient’s family for granting permission to publish this information.
2.Almoallem
B , Arno
G , De Zaeytijd
J ,
et al. The majority of autosomal recessive nanophthalmos and posterior microphthalmia can be attributed to biallelic sequence and structural variants in
MFRP and
PRSS56.
Sci Rep. 2020;10(1):1289. doi:
10.1038/s41598-019-57338-2Google ScholarCrossref